Koelis is a leader in prostate cancer diagnosis and treatment, offering a fully integrated ultrasound image-guided system.
The Company’s products have regulatory clearances and have been commercialized in the US, Europe, and most Asian markets. The Koelis Trinity™ System offers market-leading features including MRI ultrasound fusion imaging, organ tracking, robotic assistance, and focal therapy. The Koelis system is an important new technology that enables urologists to more accurately diagnose prostate cancer and can offer patients less invasive, non-radical treatment choices. The Company is based in Grenoble, France and Princeton, New Jersey, USA, and has an office in Hong Kong.
InnovaHealth Partners invested in Koelis in September 2019. Mortimer Berkowitz III currently serves as Chairman, and John McCormick and Richard B. Emmitt are Directors of Koelis.
